Works matching IS 13889842 AND DT 2021 AND VI 23 AND IP 6

Results: 32
    1
    2

    Issue Information.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. i, doi. 10.1002/ejhf.2099
    Publication type:
    Article
    3

    The war on heart failure.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 915, doi. 10.1002/ejhf.2217
    By:
    • Braunwald, Eugene
    Publication type:
    Article
    4
    5
    6
    7

    The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 933, doi. 10.1002/ejhf.2201
    By:
    • Raafs, Anne G.;
    • Verdonschot, Job A.J.;
    • Henkens, Michiel T.H.M.;
    • Adriaans, Bouke P.;
    • Wang, Ping;
    • Derks, Kasper;
    • Abdul Hamid, Myrurgia A.;
    • Knackstedt, Christian;
    • Empel, Vanessa P.M.;
    • Díez, Javier;
    • Brunner‐La Rocca, Hans‐Peter;
    • Brunner, Han G.;
    • González, Arantxa;
    • Bekkers, Sebastiaan C.A.M.;
    • Heymans, Stephane R.B.;
    • Hazebroek, Mark R.
    Publication type:
    Article
    8

    Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 895, doi. 10.1002/ejhf.2198
    By:
    • Garcia‐Pavia, Pablo;
    • Bengel, Frank;
    • Brito, Dulce;
    • Damy, Thibaud;
    • Duca, Franz;
    • Dorbala, Sharmila;
    • Nativi‐Nicolau, Jose;
    • Obici, Laura;
    • Rapezzi, Claudio;
    • Sekijima, Yoshiki;
    • Elliott, Perry M.
    Publication type:
    Article
    9
    10

    Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 872, doi. 10.1002/ejhf.2206
    By:
    • Rosano, Giuseppe M.C.;
    • Moura, Brenda;
    • Metra, Marco;
    • Böhm, Michael;
    • Bauersachs, Johann;
    • Ben Gal, Tuvia;
    • Adamopoulos, Stamatis;
    • Abdelhamid, Magdy;
    • Bistola, Vasiliki;
    • Čelutkienė, Jelena;
    • Chioncel, Ovidiu;
    • Farmakis, Dimitrios;
    • Ferrari, Roberto;
    • Filippatos, Gerasimos;
    • Hill, Loreena;
    • Jankowska, Ewa A.;
    • Jaarsma, Tiny;
    • Jhund, Pardeep;
    • Lainscak, Mitja;
    • Lopatin, Yuri
    Publication type:
    Article
    11
    12

    Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics.

    Published in:
    2021
    By:
    • Jering, Karola S.;
    • Claggett, Brian;
    • Pfeffer, Marc A.;
    • Granger, Christopher;
    • Køber, Lars;
    • Lewis, Eldrin F.;
    • Maggioni, Aldo P.;
    • Mann, Douglas;
    • McMurray, John J.V.;
    • Rouleau, Jean‐Lucien;
    • Solomon, Scott D.;
    • Steg, Philippe G.;
    • Meer, Peter;
    • Wernsing, Margaret;
    • Carter, Katherine;
    • Guo, Weinong;
    • Zhou, Yinong;
    • Lefkowitz, Martin;
    • Gong, Jianjian;
    • Wang, Yi
    Publication type:
    journal article
    13

    Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 854, doi. 10.1002/ejhf.2190
    By:
    • Seferović, Petar M.;
    • Tsutsui, Hiroyuki;
    • McNamara, Dennis M.;
    • Ristić, Arsen D.;
    • Basso, Cristina;
    • Bozkurt, Biykem;
    • Cooper, Leslie T.;
    • Filippatos, Gerasimos;
    • Ide, Tomomi;
    • Inomata, Takayuki;
    • Klingel, Karin;
    • Linhart, Aleš;
    • Lyon, Alexander R.;
    • Mehra, Mandeep R.;
    • Polovina, Marija;
    • Milinković, Ivan;
    • Nakamura, Kazufumi;
    • Anker, Stefan D.;
    • Veljić, Ivana;
    • Ohtani, Tomohito
    Publication type:
    Article
    14

    The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC‐HF).

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 1052, doi. 10.1002/ejhf.2181
    By:
    • Biering‐Sørensen, Tor;
    • Minamisawa, Masatoshi;
    • Liu, Jiankang;
    • Claggett, Brian;
    • Papolos, Alexander I.;
    • Felker, G. Michael;
    • McMurray, John J.V.;
    • Legg, Jason C.;
    • Malik, Fady I.;
    • Honarpour, Narimon;
    • Kurtz, Christopher E.;
    • Teerlink, John R.;
    • Solomon, Scott D.
    Publication type:
    Article
    15
    16
    17
    18
    19

    The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019.

    Published in:
    2021
    By:
    • Seferović, Petar M.;
    • Vardas, Panagiotis;
    • Jankowska, Ewa A.;
    • Maggioni, Aldo P.;
    • Timmis, Adam;
    • Milinković, Ivan;
    • Polovina, Marija;
    • Gale, Chris P.;
    • Lund, Lars H.;
    • Lopatin, Yuri;
    • Lainscak, Mitja;
    • Savarese, Gianluigi;
    • Huculeci, Radu;
    • Kazakiewicz, Dzianis;
    • Coats, Andrew J.S.;
    • National Heart Failure Societies of the ESC member countries (see Appendix)
    Publication type:
    journal article
    20
    21
    22

    Making heart failure count.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 917, doi. 10.1002/ejhf.2148
    By:
    • Ziaeian, Boback;
    • Fonarow, Gregg C.
    Publication type:
    Article
    23
    24
    25
    26

    Use of sodium–glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 1012, doi. 10.1002/ejhf.2131
    By:
    • Becher, Peter M.;
    • Schrage, Benedikt;
    • Ferrannini, Giulia;
    • Benson, Lina;
    • Butler, Javed;
    • Carrero, Juan Jesus;
    • Cosentino, Francesco;
    • Dahlström, Ulf;
    • Mellbin, Linda;
    • Rosano, Giuseppe M.C.;
    • Sinagra, Gianfranco;
    • Stolfo, Davide;
    • Lund, Lars H.;
    • Savarese, Gianluigi
    Publication type:
    Article
    27

    Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 983, doi. 10.1002/ejhf.2144
    By:
    • Woolley, Rebecca J.;
    • Ceelen, Daan;
    • Ouwerkerk, Wouter;
    • Tromp, Jasper;
    • Figarska, Sylwia M.;
    • Anker, Stefan D.;
    • Dickstein, Kenneth;
    • Filippatos, Gerasimos;
    • Zannad, Faiez;
    • Marco, Metra;
    • Ng, Leong;
    • Samani, Nilesh;
    • Veldhuisen, Dirk J;
    • Lang, Chim;
    • Lam, Carolyn S.;
    • Voors, Adriaan A.
    Publication type:
    Article
    28
    29

    High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 919, doi. 10.1002/ejhf.2036
    By:
    • Sierpinski, Radoslaw;
    • Josiak, Krystian;
    • Suchocki, Tomasz;
    • Wojtas‐Polc, Katarzyna;
    • Mazur, Grzegorz;
    • Butrym, Aleksandra;
    • Rozentryt, Piotr;
    • Meer, Peter;
    • Comin‐Colet, Josep;
    • Haehling, Stephan;
    • Kosmala, Wojciech;
    • Przewlocka‐Kosmala, Monika;
    • Banasiak, Waldemar;
    • Nowak, Jolanta;
    • Voors, Adriaan A.;
    • Anker, Stefan D.;
    • Cleland, John G.F.;
    • Ponikowski, Piotr;
    • Jankowska, Ewa A.
    Publication type:
    Article
    30

    Issue Information.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. i, doi. 10.1002/ejhf.2099
    Publication type:
    Article
    31
    32

    Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium–glucose co‐transporter 2 inhibitor therapy in DECLARE‐TIMI 58.

    Published in:
    European Journal of Heart Failure, 2021, v. 23, n. 6, p. 1026, doi. 10.1002/ejhf.2073
    By:
    • Zelniker, Thomas A.;
    • Morrow, David A.;
    • Mosenzon, Ofri;
    • Goodrich, Erica L.;
    • Jarolim, Petr;
    • Murphy, Sabina A.;
    • Bhatt, Deepak L.;
    • Leiter, Lawrence A.;
    • McGuire, Darren K.;
    • Wilding, John;
    • Bode, Christoph;
    • Lewis, Basil S.;
    • Gause‐Nilsson, Ingrid;
    • Langkilde, Anna Maria;
    • Fredriksson, Martin;
    • Raz, Itamar;
    • Sabatine, Marc S.;
    • Wiviott, Stephen D.
    Publication type:
    Article